Charts Tell the Tale – Help Beat the S&P 500 by Four Folds -Impax Laboratories, NetSuites

Select One

Share Tweet

Charts Tell the Tale – Help Beat the S&P 500 by Four Folds -Impax Laboratories, NetSuites

(Austin, Texas). A stock chart is more than a history of price versus time. It could explain the psychology of investors in that stock, company related events, and much more. An experienced and seasoned investor can look at a stock chart, and with certain accuracy, predict how the price would behave in the future. In fact, many of the large Wall Street firms have dedicated groups of individuals that make a nice living by studying stock charts. Tradista also has chart readers who share their knowledge with its readers. Based on chart patters, Tradista recently made the following suggestions:

An August $22.5 Call Option was recommended on Impax Laboratories (NASDAQ: IPXL) , the secialty pharmaceutical company, at $1.60 on August 6th. At the time, the stock was trading at $23.95. IPXL chart had formed a “bullish flag” and Tradista chart readers predicted higher prices for the stock. Ten days later, the stock popped pushing the value of the recommended call option to $1.80. The position was closed with a solid return of 12.5%. See for details of the selection.

On August 20, 2012, NetSuite (NYSE:N), the financial software maker, was recommended at $56.40. Shares had formed a bullish "flag" and were consolidating in that formation. On September 13, 2012, the position was closed at $62.45, after shares broke out of the formation for a solid gain of 11%

Do all of our recommendations have these kinds of returns? The answer is no but most of them do. So do your portfolio a favor and visit our web site. You will be surprised to see how easy we have made it.

For a current list of Tradista recommendations, performance and holdings, please refer to

Free two-week on-line trial subscriptions to are available at The trial membership does not require the use of a credit card. The company may be reached at 972-63TRADE.

Tradista is not a registered broker dealer or a registered investment adviser. No information accessed through the Tradista Web site, or any link contained on the Tradista Web site, constitutes a recommendation by Tradista to buy, sell or hold any security, financial product, or instrument discussed therein. Information accessed through linked sites neither is, nor should be construed as, an offer, or a solicitation of an offer, to buy or sell securities by Tradista. Tradista may or may not hold positions in securities being discussed in this news release and/or mentioned on the Tradista Web site. Investors shall be fully responsible for any investment decisions they make, and such decisions will be based solely on their evaluation of their financial circumstances, investment objectives, risk tolerance and liquidity needs. Investors are encouraged to consult with their registered broker and/or investment adviser before making any investment decision.